Jamie Christensen - Sep 8, 2023 Form 4 Insider Report for Mirati Therapeutics, Inc. (MRTX)

Role
EVP & Chief Scientific Officer
Signature
/s/ John Moriarty, Attorney-in-Fact
Stock symbol
MRTX
Transactions as of
Sep 8, 2023
Transactions value $
-$85,084
Form type
4
Date filed
9/12/2023, 05:41 PM
Previous filing
Aug 10, 2023
Next filing
Dec 19, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Sale -$85.1K -2.39K -1.63% $35.63 144K Sep 8, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the performance stock units (PSUs) granted on June 25, 2021.